This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 994
From Proteopedia
(Difference between revisions)
| Line 26: | Line 26: | ||
[[Image:B-lactam hydrolysis3.png|800px|left|thumb|alt=text|β-lactam antibiotics (basic structure of a β-lactam is shown above) are hydrolyzed by β-lactamase enzymes, utilizing a covalent catalysis serine-based mechanism. The β-lactamase cleaves the amide bond of the four membered ring which renders the antibiotic inactive before it reaches its bacterial target, the transpeptidase enzymes.]] | [[Image:B-lactam hydrolysis3.png|800px|left|thumb|alt=text|β-lactam antibiotics (basic structure of a β-lactam is shown above) are hydrolyzed by β-lactamase enzymes, utilizing a covalent catalysis serine-based mechanism. The β-lactamase cleaves the amide bond of the four membered ring which renders the antibiotic inactive before it reaches its bacterial target, the transpeptidase enzymes.]] | ||
| - | [[Image:Beta-lactamase resized mechanism.png|500px| | + | [[Image:Beta-lactamase resized mechanism.png|500px|none|thumb|alt=text|The mechanism of attack involves a catalytic serine residue, a carboxylated lysine, and another active site serine which contributes to proton movement (A). A high energy tetrahedral intermediate (B) is generated and an acyl enzyme intermediate (C) is formed after the cleavage of the four-membered ring. KCX84 activates the deacylating water which completes the reaction leaving a hydrolyzed β-lactam ring and a regenerated β-lactamase.<ref name="Leonard" />]] |
<scene name='69/691536/Closeupdrug/1'>close up</scene><ref>PMID: 10817708</ref> | <scene name='69/691536/Closeupdrug/1'>close up</scene><ref>PMID: 10817708</ref> | ||
Revision as of 15:59, 27 February 2015
| This Sandbox is Reserved from 20/01/2015, through 30/04/2016 for use in the course "CHM 463" taught by Mary Karpen at the Grand Valley State University. This reservation includes Sandbox Reserved 987 through Sandbox Reserved 996. |
To get started:
More help: Help:Editing |
OXA-24 β-lactamase
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ Bauman, Robert W. "Controlling Microbial Growth in the Body: Antimicrobial Drugs." In Microbiology with Diseases by Taxonomy, 287-288. 4th ed. Glenview, IL: Pearson, 2014.
- ↑ Bauman, Robert W. "Controlling Microbial Growth in the Body: Antimicrobial Drugs." In Microbiology with Diseases by Taxonomy, 299. 4th ed. Glenview, IL: Pearson, 2014.
- ↑ 5.0 5.1 Bou, German, Antonio Oliver, and Jesus Martinez-Beltran. "OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter Baumannii Clinical Strain." Antimicrobial Agents and Chemotherapy 44, no. 6 (2000): 1556-561. Accessed February 19, 2015. http://aac.asm.org/content/44/6/1556.full
- ↑ Dijkshoorn, Lenie, Alexandr Nemec, and Harald Seifert. "An Increasing Threat in Hospitals: Multidrug-resistant Acinetobacter Baumannii." Nature Reviews Microbiology 5, no. 12 (2007): 939-51. Accessed February 19, 2015. http://www.nature.com/nrmicro/journal/v5/n12/full/nrmicro1789.html
- ↑ 7.0 7.1 7.2 7.3 7.4 7.5 Leonard DA, Bonomo RA, Powers RA. Class D beta-lactamases: a reappraisal after five decades. Acc Chem Res. 2013 Nov 19;46(11):2407-15. doi: 10.1021/ar300327a. Epub 2013 Jul, 31. PMID:23902256 doi:http://dx.doi.org/10.1021/ar300327a
- ↑ doi: https://dx.doi.org/10.3390/antibiotics3020128#sthash.iyPihLj1.dpuf
- ↑ PMCID: PMC162717
- ↑ Patrick, G. (2005). Antibacterial Agents. An Introduction to Medicinal Chemistry (3rd Ed), pages 388-414.
- ↑ Meroueh, S.O; Minasov, G; Lee, W; Shoichet, B.K; Mobashery, S. Structural aspects for evolution of beta-lactamases from penicillin-binding proteins. J. Am. Chem Soc. (2003), 125, 9612-9618.
- ↑ Neu, Harold. "The Crisis in Antibiotic Resistance." Science (1992) 257, 5073. ProQuest Medical Library: p. 1064-1072.
- ↑ Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010 Mar;54(3):969-76. doi: 10.1128/AAC.01009-09., Epub 2009 Dec 7. PMID:19995920 doi:http://dx.doi.org/10.1128/AAC.01009-09
- ↑ 14.0 14.1 PMCID: PMC1838445
- ↑ Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother. 2000 Jun;44(6):1556-61. PMID:10817708

